- About us
- Technology Transfer Offices
- Research Scientists
- Life Science Companies
- Commercial Life Science Biotech and Pharma Companies
- Ximbassador Programme
Over the last 25 years
Commercial Partnerships has built one of the largest and most well respected
collections of reagents in the UK.
Cancer Research Technology (CRT) is formed by merging Cancer Research Campaign Technologies, Cancer Research Ventures and Imperial Cancer Research Technology.
The DaRT (Diagnostic and Research Tools) team is formed to develop the reagent licensing and commercialisation business within CRT.
CRT Inc, CRT’s American division is formed.
Commercial Partnerships rebrands and relaunches DaRT as Ximbio, to change the way reagents
are licensed, sourced and stored.
Ximbio partners with more than 20 UK TTOs, researchers and
life science companies.
CRT becomes CRUK Commercial Partnerships
Ximbio expands into the US, partnering with over 30 US institutes
Ximbio has partnerships with more than 80 TTOs, over 1000 researchers
and more than 200 life science companies worldwide.